Deinde

DEINDE sells skin-care treatments built around “neuro-age” science: four-step regimens, targeted boosters, and daily SPF. Products sit in the premium tier—most 30-50 ml serums and creams retail $85-$140—and are sold exclusively through deinde.com, shipped direct from California. The brand’s hook is patented niacinamide-based “NAD+” complexes that claim to restore cellular energy depleted by stress and screen exposure. Launch standout “Face & Neck Regenerating Set” sold out its first 5,000 units in two weeks, driven by before-and-after clinical data showing 32 % wrinkle reduction in eight weeks. Core buyers are 28-45-year-old urban professionals who track bio-marker scores, use Whoop or Oura, and want dermatologist-level results without Rx visits. Messaging stresses “future-proofing” skin, aligning with longevity, clean-label, and science-first values; 68 % of customers self-identify as tech workers. DEINDE competes in the fast-growing “biotech beauty” space against brands pushing stem-cell, peptide, or gene-based actives. It differentiates by linking neuro-aging research to topical NAD+ delivery, publishing peer-reviewed citations, and limiting SKUs to a tightly curated system rather than an endless aisle.